🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Implementing REmote SymPtom mOnitoring and maNagement (RESPONd)

RecruitingNAAges 18 Years - anyAllUniversity of Calgary
NCT07024329 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this study is to understand if the implementation of a remote symptom monitoring and management program improves outcomes. The program will provide patients the opportunity to complete electronic Patient Reported Outcomes (PROs) questionnaires from home between appointments and receive tailored advice from a study nurse. A second goal of this study is to examine the impact of electronic symptom monitoring on clinic efficiencies. The main question it aims to answer is: • What impact does implementing digitally enabled remote symptom monitoring and management (RESPONd) between ambulatory oncology visits have on patient outcomes and system efficiencies? Participants will: * Report their symptoms and concerns from home by completing the electronic symptom monitoring questionnaire. * Discuss their symptoms and concerns with a study nurse. * Provide feedback about their experie

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 * Have cancer * Receiving care in one of the participating clinics. * Able to sign up for MyAHS Connect and consent. * Have access to a digital device at home * Able to complete their electronic PROs questionnaire without support from the clinic team on a weekly (patients on active treatment) or monthly (patients on follow-up) basis, for the duration of the intervention or until they are discharged from the clinic. * Regular access to a telephone in order for the study nurse to call patients to provide symptom management support. Exclusion Criteria: * Patients with cognitive disabilities or who cannot reliably report symptoms independently. * Patients not residing in Alberta, as government-issued ID is required to register for MyAHS Connect. * Patients who do not have regular access to a telephone, as the study nurse needs to be able to call patients to provide symptom management support. * Patients who do not speak English, or who do not have an English-speaking friend, family member, or caregiver to assist them, as the electronic PROs questionnaire is only available in English at this time.
💊

What it tests

  • Remote Symptom Monitoring and Management
  • Clinic Team Huddle
📍

Where

4 sites
Arthur J. E. Child Comprehensive Cancer Centre
Calgary, Canada
Cross Cancer Institute
Edmonton, Canada
High River Community Cancer Centre
High River, Canada
Central Alberta Cancer Centre
Red Deer, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy